19 May 2013
Keywords: amgen, kepivance, gets, nod, chmp, biotechnology, major
Article | 08 August 2005
US biotechnology major Amgen has received a positive marketing authorization opinion from the European Committee for Medicinal
Products for Human ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 August 2005
17 May 2013
© 2013 thepharmaletter.com